Fibronectin Molecular Status in Plasma of Women with Endometriosis and Fertility Disorders

The diagnosis of endometriosis and fertility disorders is difficult; therefore, it is necessary to look for reliable biomarkers. Analysis of the molecular status of fibronectin as a key player in repair and wound healing processes, as well as in coagulation and fibrinolysis pathways, is justified. E...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jolanta Lis-Kuberka, Paulina Kubik, Agnieszka Chrobak, Jarosław Pająk, Anna Chełmońska-Soyta, Magdalena Orczyk-Pawiłowicz
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/57333a0be7f04b398f534741996659c4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:57333a0be7f04b398f534741996659c4
record_format dspace
spelling oai:doaj.org-article:57333a0be7f04b398f534741996659c42021-11-11T16:53:18ZFibronectin Molecular Status in Plasma of Women with Endometriosis and Fertility Disorders10.3390/ijms2221114101422-00671661-6596https://doaj.org/article/57333a0be7f04b398f534741996659c42021-10-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11410https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067The diagnosis of endometriosis and fertility disorders is difficult; therefore, it is necessary to look for reliable biomarkers. Analysis of the molecular status of fibronectin as a key player in repair and wound healing processes, as well as in coagulation and fibrinolysis pathways, is justified. ELISA and SDS-agarose immunoblotting were applied to determine the fibronectin concentration and presence and occurrence of soluble FN-fibrin complexes in the blood plasma of women with endometriosis (n = 38), fertility disorders (n = 28) and the healthy group (n = 25). The concentration of fibronectin in the blood plasma of women with endometriosis (292.61 ± 96.17 mg/L) and fertility disorders (287.53 ± 122.68 mg/L) was significantly higher than in the normal group (226.55 ± 91.98 mg/L). The presence of FN-fibrin complexes of 750, 1000, 1300, 1600 and 1900 kDa in the plasma of women with endometriosis and fertility disorders was shown. The presence of FN-fibrin complexes with a molecular mass of more than 1300 kDa in women with endometriosis and infertility and the complete absence of these complexes in healthy women may indicate an increased and chronic activation of coagulation mechanisms in these patients. The presence of complexes of high molecular mass may be one of the biomarkers of fertility disorders in women.Jolanta Lis-KuberkaPaulina KubikAgnieszka ChrobakJarosław PająkAnna Chełmońska-SoytaMagdalena Orczyk-PawiłowiczMDPI AGarticleendometriosisfertility disordersmolecular status of fibronectinfibrinBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11410, p 11410 (2021)
institution DOAJ
collection DOAJ
language EN
topic endometriosis
fertility disorders
molecular status of fibronectin
fibrin
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle endometriosis
fertility disorders
molecular status of fibronectin
fibrin
Biology (General)
QH301-705.5
Chemistry
QD1-999
Jolanta Lis-Kuberka
Paulina Kubik
Agnieszka Chrobak
Jarosław Pająk
Anna Chełmońska-Soyta
Magdalena Orczyk-Pawiłowicz
Fibronectin Molecular Status in Plasma of Women with Endometriosis and Fertility Disorders
description The diagnosis of endometriosis and fertility disorders is difficult; therefore, it is necessary to look for reliable biomarkers. Analysis of the molecular status of fibronectin as a key player in repair and wound healing processes, as well as in coagulation and fibrinolysis pathways, is justified. ELISA and SDS-agarose immunoblotting were applied to determine the fibronectin concentration and presence and occurrence of soluble FN-fibrin complexes in the blood plasma of women with endometriosis (n = 38), fertility disorders (n = 28) and the healthy group (n = 25). The concentration of fibronectin in the blood plasma of women with endometriosis (292.61 ± 96.17 mg/L) and fertility disorders (287.53 ± 122.68 mg/L) was significantly higher than in the normal group (226.55 ± 91.98 mg/L). The presence of FN-fibrin complexes of 750, 1000, 1300, 1600 and 1900 kDa in the plasma of women with endometriosis and fertility disorders was shown. The presence of FN-fibrin complexes with a molecular mass of more than 1300 kDa in women with endometriosis and infertility and the complete absence of these complexes in healthy women may indicate an increased and chronic activation of coagulation mechanisms in these patients. The presence of complexes of high molecular mass may be one of the biomarkers of fertility disorders in women.
format article
author Jolanta Lis-Kuberka
Paulina Kubik
Agnieszka Chrobak
Jarosław Pająk
Anna Chełmońska-Soyta
Magdalena Orczyk-Pawiłowicz
author_facet Jolanta Lis-Kuberka
Paulina Kubik
Agnieszka Chrobak
Jarosław Pająk
Anna Chełmońska-Soyta
Magdalena Orczyk-Pawiłowicz
author_sort Jolanta Lis-Kuberka
title Fibronectin Molecular Status in Plasma of Women with Endometriosis and Fertility Disorders
title_short Fibronectin Molecular Status in Plasma of Women with Endometriosis and Fertility Disorders
title_full Fibronectin Molecular Status in Plasma of Women with Endometriosis and Fertility Disorders
title_fullStr Fibronectin Molecular Status in Plasma of Women with Endometriosis and Fertility Disorders
title_full_unstemmed Fibronectin Molecular Status in Plasma of Women with Endometriosis and Fertility Disorders
title_sort fibronectin molecular status in plasma of women with endometriosis and fertility disorders
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/57333a0be7f04b398f534741996659c4
work_keys_str_mv AT jolantaliskuberka fibronectinmolecularstatusinplasmaofwomenwithendometriosisandfertilitydisorders
AT paulinakubik fibronectinmolecularstatusinplasmaofwomenwithendometriosisandfertilitydisorders
AT agnieszkachrobak fibronectinmolecularstatusinplasmaofwomenwithendometriosisandfertilitydisorders
AT jarosławpajak fibronectinmolecularstatusinplasmaofwomenwithendometriosisandfertilitydisorders
AT annachełmonskasoyta fibronectinmolecularstatusinplasmaofwomenwithendometriosisandfertilitydisorders
AT magdalenaorczykpawiłowicz fibronectinmolecularstatusinplasmaofwomenwithendometriosisandfertilitydisorders
_version_ 1718432238215888896